Nomura Maintains Buy on Solid Biosciences, Lowers Price Target to $6

Nomura maintains Solid Biosciences (NASDAQ:SLDB) with a Buy and lowers the price target from $22 to $6.

Benzinga · 11/13/2019 14:46

Nomura maintains Solid Biosciences (NASDAQ:SLDB) with a Buy and lowers the price target from $22 to $6.